Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension

NCT00765674 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1191

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Aliskiren
DRUG: Amlodipine
DRUG: Hydrochlorothiazide (HCTZ)
DRUG: Placebo
DRUG: Placebo

Sponsor

Novartis